These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 7640060)
1. Genetic testing of the common cancers: potential and problems. Ponder BA Eur J Cancer; 1995; 31A(5):807-8. PubMed ID: 7640060 [No Abstract] [Full Text] [Related]
2. Relative values. Millar B Nurs Stand; 2005 Aug 17-23; 19(49):24-6. PubMed ID: 16134413 [TBL] [Abstract][Full Text] [Related]
3. Are we ready to use genetic testing to diagnose predisposition to cancer? Farrell CD; MacDonald DJ ONS News; 1995 Aug; 10(8):4. PubMed ID: 7478627 [No Abstract] [Full Text] [Related]
4. [Oncogenetics: a new activity between research and medicine]. Bourret P; Stemerding D; Koch L Bull Cancer; 1998 Mar; 85(3):239-42. PubMed ID: 9752312 [TBL] [Abstract][Full Text] [Related]
5. Breast cancer and gene testing: risk, rationale, and responsibilities of primary care providers. Wilcox-Honnold PM Lippincotts Prim Care Pract; 1998; 2(3):271-83. PubMed ID: 9644442 [TBL] [Abstract][Full Text] [Related]
6. How do we apply genetic testing for breast cancer susceptibility to clinical practice? Hughes KS; Roche CA J Surg Oncol; 1996 Jul; 62(3):155-7. PubMed ID: 8667620 [No Abstract] [Full Text] [Related]
7. Popularity of breast cancer program leads to referral protocols in BC. Kent H CMAJ; 1998 Oct; 159(7):832-3. PubMed ID: 9805033 [TBL] [Abstract][Full Text] [Related]
8. Adherence patterns to National Comprehensive Cancer Network (NCCN) guidelines for referral to cancer genetic professionals. Febbraro T; Robison K; Wilbur JS; Laprise J; Bregar A; Lopes V; Legare R; Stuckey A Gynecol Oncol; 2015 Jul; 138(1):109-14. PubMed ID: 25933682 [TBL] [Abstract][Full Text] [Related]
9. Multitiered Questions Regarding Multigene Testing for Cancer Susceptibility. Newman LA JAMA Surg; 2018 Nov; 153(11):983-984. PubMed ID: 30264135 [No Abstract] [Full Text] [Related]
10. Breast & ovarian cancer. Issues in risk assessment. Caro SW Adv Nurse Pract; 1999 Aug; 7(8):26-32; quiz 33-4. PubMed ID: 10745719 [No Abstract] [Full Text] [Related]
11. [Oncogenetics: how far, and what for?]. Noguès C Bull Cancer; 1998 Mar; 85(3):243-5. PubMed ID: 9752313 [TBL] [Abstract][Full Text] [Related]
12. Psychosocial impact of the lack of information given at referral about familial risk for cancer. Metcalfe A; Werrett J; Burgess L; Clifford C Psychooncology; 2007 May; 16(5):458-65. PubMed ID: 16933207 [TBL] [Abstract][Full Text] [Related]
13. Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling? Powell CB; Littell R; Hoodfar E; Sinclair F; Pressman A Int J Gynecol Cancer; 2013 Mar; 23(3):431-6. PubMed ID: 23354368 [TBL] [Abstract][Full Text] [Related]
14. Genetic predisposition testing for breast cancer. Audeh MW Cancer J Sci Am; 1997; 3(4):254-5. PubMed ID: 9263632 [No Abstract] [Full Text] [Related]
17. For the benefit of all. Durfy SJ; Peters JA Hastings Cent Rep; 1993; 23(5):28-9; discussion 29-30. PubMed ID: 8262767 [No Abstract] [Full Text] [Related]
18. Nucleic acids in diagnosis (Part II): Genetic testing and screening. Datar RH Natl Med J India; 2001; 14(2):93-8. PubMed ID: 11396327 [No Abstract] [Full Text] [Related]
19. Provider Discussions of Genetic Tests With U.S. Women at Risk for a BRCA Mutation. Hull LE; Haas JS; Simon SR Am J Prev Med; 2018 Feb; 54(2):221-228. PubMed ID: 29241717 [TBL] [Abstract][Full Text] [Related]
20. Genetic testing for breast and ovarian cancer susceptibility: a family experience. Van Riper M; McKinnon WC J Midwifery Womens Health; 2004; 49(3):210-9. PubMed ID: 15134674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]